Xencor (XNCR) Selling, General & Administrative (2013 - 2026)
Xencor (XNCR) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Xencor | 1.50 Bn | 1.11 Bn | - | 17.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.71 Mn |
| Dec 31, 2025 | 17.04 Mn |
| Sep 30, 2025 | 14.15 Mn |
| Jun 30, 2025 | 15.12 Mn |
| Mar 31, 2025 | 17.34 Mn |
| Dec 31, 2024 | 14.92 Mn |
| Sep 30, 2024 | 14.77 Mn |
| Jun 30, 2024 | 17.75 Mn |
| Mar 31, 2024 | 13.79 Mn |
| Dec 31, 2023 | 15.48 Mn |
| Sep 30, 2023 | 12.49 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Mar 31, 2023 | 13.95 Mn |
| Dec 31, 2022 | 12.75 Mn |
| Sep 30, 2022 | 12.37 Mn |
| Jun 30, 2022 | 11.09 Mn |
| Mar 31, 2022 | 11.27 Mn |
| Dec 31, 2021 | 11.38 Mn |
| Sep 30, 2021 | 10.37 Mn |
| Jun 30, 2021 | 8.86 Mn |